Chemical Compound

879562-26-2

CAS Registry Number 879562-26-2
879562-26-2 chemical structure
Primary Record

879562-26-2

In stock
4,624 g
Purity
98.7 %
CAS
879562-26-2

Compound Identifiers & Properties

CAS
879562-26-2
PubChem CID
44193132
SMILES
CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(=C)C
Canonical SMILES
C=C(C)c1nc(CCC)n(Cc2ccc(-c3ccccc3-c3nn[nH]n3)cc2)c1C(=O)OCc1oc(=O)oc1C

Names & Synonyms

  • 879562-26-2
  • Dehydro Olmesartan Medoxomil
  • Olmesartan medoxomil impurity C
  • Olmesartan EP Impurity C
  • Olmesartan EP imp C
  • SCHEMBL102109
  • MFCD16660960
  • Olmesartan medoxomil impurity I
  • C29H28N6O5
  • orb1694123
  • UNII-227N84S103
  • Olmesartan Impurity RNH 6373
  • Olmesartan Medoxomil EP Impurity C
  • SCHEMBL29699164
  • DTXSID80236724
  • PSFJJUXSEHXDFN-UHFFFAOYSA-N
  • (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H-imidazole-5-carboxylate
  • 4020AC
  • Olmesartan Medoxomilum EP Impurity C
  • ZINC72131104
  • AKOS040754980
  • DES(1-hydroxy-1-methylethyl)-(1-methylethenyl)-olmesartan medoxomil
  • ACN-026595
  • CS-T-51788
  • RP17779
  • 227N84S103
  • 4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-Imidazole-5-carboxylic acid(5-methyl-2-oxo-1,3-dioxol-4-yl)methylester
  • IO175875
  • SY288726
  • Olmesartan medoxomil specified impurity C [EP]
  • HY-131264
  • CS-0131952
  • FT-0689613
  • F19240
  • A900050
  • Olmesartan Medoxomil Impurity C (Dehydro Impurity)
  • Olmesartan medoxomil impurity, olefinic impurity- [USP]
  • (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-prop-1-en-2-yl-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
  • OLMESARTAN MEDOXOMIL IMPURITY C [EP IMPURITY]
  • Q27253622
  • B2694-445733
  • (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-methylethenyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylate
  • 1H-Imidazole-5-carboxylic acid, 4-(1-methylethenyl)-2-propyl-1-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
  • 4-(1-methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-Imidazole-5-carboxylic acid(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
  • OLMESARTAN MEDOXOMIL IMPURITY, OLEFINIC IMPURITY- [USP IMPURITY]
  • Dehydro Olmesartan Medoxomil; (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-
  • (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H-imidazole-5-carboxylate
  • (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H-imidazole-5-carboxylate
  • (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-[[2 inverted exclamation mark -(5-Tetrazolyl)-4-biphenylyl]methyl]-4-(1-propen-2-yl)-2-propylimidazole-5-carboxylate
  • (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-Methylethenyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylate
  • (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-isopropenyl-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
  • (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-isopropenyl-2-propyl-1-[[2'-[1H-tetrazol-5-yl]biphenyl-4-yl]methyl]imidazole-5-carboxylate
  • (5-Methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(prop-1-en-2-yl)-2-propyl-1-{[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylate
  • 1H-Imidazole-5-carboxylic acid, 4-(1-methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; 1H-Imidazole-5-carboxylic acid, 4-(1-methylethenyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; Olmesartan Medoxomil Imp C (EP); Olmesartan Medoxomil Impurity C
  • 4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-Imidazole-5-carboxylic acid(5-methyl-2-oxo-1,3-dioxol-4-yl)methylester
  • 4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester
  • methylethenyl)-2-propyl-1-[[2?-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylate,
  • Olmesartan EP Impurity C/ Olmesartan Medoxomil Olefinic Impurity USP (Dehydro Olmesartan Medoxomil/ Anhydro Olmesartan Medoxomil)